Bio-Kinetic Clinical Applications General Information
Provider of Phase I clinical study services. The company designs and conducts Phase I clinical studies for branded pharmaceutical, bio-technology, and generic drug companies. It owns and operates a 240-bed Phase I facility in Springfield, Missouri. Its services include protocol development, phase I and III clinical pharmacology, safety and tolerance studies, bioequivalence/bioavailability, pharmacokinetic/pharmacodynamic, drug/drug interaction, food effect, QTC intervals, rising dose tolerance, and data management.